Cargando…
Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art
The pharmacodynamics of the purinergic receptor type Y, subtype 12 (P2Y12) inhibitors has evolved. Our understanding of the metabolism of P2Y12 inhibitors has revealed polymorphisms that impact drug metabolism and antiplatelet efficacy, leading to genetic testing guided therapy. In addition, assays...
Autores principales: | Al-abcha, Abdullah, Radwan, Yasser, Blais, Danielle, Mazzaferri, Ernest L., Boudoulas, Konstantinos Dean, Essa, Essa M., Gumina, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983962/ https://www.ncbi.nlm.nih.gov/pubmed/35402528 http://dx.doi.org/10.3389/fcvm.2022.850028 |
Ejemplares similares
-
Right Ventricular Myocardial Infarction Complicated by Cardiac Arrest: Utilization of Extracorporeal Membrane Oxygenation
por: Alabre-Bonsu, Alisha, et al.
Publicado: (2022) -
Extracorporeal Cardiopulmonary Resuscitation for Management of Out-of-Hospital Cardiac Arrest in a Patient with Fulminant Myocarditis
por: Meyer, Alexander J., et al.
Publicado: (2020) -
De novo Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions
por: Alvi, Syed Baseeruddin, et al.
Publicado: (2021) -
Editorial: Novel and emerging therapies in heart failure
por: Giamouzis, Grigorios, et al.
Publicado: (2023) -
Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)